# US 2022/0033477 A1 · Liquid composition for oral ingestion containing collagen peptide and method for suppressing foaming of liquid composition for oral ingestion

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0033477 A1
- Document ID: US20220033477A1
- Status: Published application
- Kind: A1
- Application number: 17/297,885
- Filed: 2019-11-29
- Published: 2022-02-03
- Earliest claimed: 2018-11-30
- Assignees: Suntory Holdings Limited
- Applicants: Suntory Holdings Limited
- Inventors: Wakana Taguchi; Takako Imao; Naoki Kasajima; Megumi Endo
- Web page: https://patentgrep.com/patent/US20220033477A1

## CPC

- C07K 14/78: Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
- A23L 2/52: Adding ingredients (adding preservatives A23B70/10)
- A23L 2/62: Clouding agents; Agents to improve the cloud-stability
- A23L 2/66: Proteins
- A23L 33/18: Peptides; Protein hydrolysates
- A61K 9/0095: {Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches (A61K9/0007 takes precedence; eatable gels or foams A61K9/0056; oral mucosa adhesive forms A61K9/006)}
- A23V 2002/00: Food compositions, function of food ingredients or processes for food or foodstuffs
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A23V: INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION

## Abstract

The present invention aims to provide a technique that can suppress foaming of liquid oral compositions containing collagen peptides. The present invention relates to a liquid oral composition containing collagen peptides containing Pro-Hyp, wherein an amount of Pro-Hyp is 1.0 to 180 mg/100 mL, and the like.

## Claims

### Claim 1

A liquid oral composition comprising:
collagen peptides containing Pro-Hyp,
wherein an amount of Pro-Hyp is 1.0 to 180 mg/100 mL.

### Claim 2 (depends on 1)

The liquid oral composition according to claim 1,
wherein the amount of Pro-Hyp is 10 to 180 mg/100 mL.

### Claim 3 (depends on 1)

The liquid oral composition according to claim 1,
wherein the liquid oral composition is a packaged beverage.

### Claim 4

A method of suppressing foaming of a liquid oral composition containing collagen peptides, the method comprising:
adjusting an amount of Pro-Hyp in the liquid oral composition to 1.0 to 180 mg/100 mL.

### Claim 5

A method of producing a liquid oral composition, the method comprising:
mixing collagen peptides with an aqueous medium so that an amount of Pro-Hyp is 1.0 to 180 mg based on 100 mL of the liquid oral composition.
